Alex Zhavoronkov
Alex Zhavoronkov is a scientist working in biotechnology, regenerative medicine and aging economics. He is founder of Insilico Medicine, the director of the Biogerontology Research Foundation, a UK-based think-tank for aging research, and the director of the International Aging Research Portfolio, an open-access repository of biomedical grants. He is also an adjunct professor at the Moscow Institute of Physics and Technology.[1]
EducationПравить
Zhavoronkov earned two bachelor's degrees at Queen's University in computer science and commerce. He has a master's in biotechnology from Johns Hopkins University and a PhD in physics and mathematics from Moscow State University.[2]
CareerПравить
He is the co-founder and CEO of Insilico Medicine, a deep learning company focused on drug discovery[3] and biomarker development for aging and aging-associated diseases located at the Emerging Technology Centers of the Johns Hopkins University.[4][5]
Since 2011, Dr. Zhavoronkov authored and co-authored over 108 scientific articles published in refereed journals[6] with over 85 papers referenced in PubMed.[7] Many of the highest-impact research papers focus on the applications of deep learning techniques to drug discovery, biomarker development, and aging research.[8]
In November 2017 together with the collaborators from the BitFury Group he proposed the application of the deep learning techniques and blockchain technology for managing human life data[9], [10], [11],[12] and presented the concept at the Singularity University Exponential Medicine conference in San Diego.[13][14]
Dr. Zhavoronkov is the editor of Aging[15] and associate editor of Frontiers in Genetics of Aging.[16] He co-founded the "Annual Aging Research for Drug Discovery Forum" in Basel, Switzerland in 2014, previously called the International Symposium on Geroprotectors [17] as part of the EMBO/Basel Life.[18]
BooksПравить
ReferencesПравить
- ↑ MIPT MIPT News: Neural network learns to select potential anticancer drugs 02.09.2017
- ↑ Executive Profile of Alexander Zhavoronkov Bloomberg.com
- ↑ Artificial Intelligence: will it change the way drugs are discovered? Pharmaceutical Journal, The Journal of the Royal Pharmacological Society
- ↑ GenomeWeb: In Silico Medicine Opens US Office, Prepares to Launch Drug Discovery Software for Aging Research Market by Uduak Grace Thomas, March 28, 2014
- ↑ Baltimore Sun, Insilico Medicine raises $10 million, by Sarah Gantz, February 23, 2017
- ↑ Google Scholar by Publication Date Google Scholar by Publication Date
- ↑ PubMed Bibliography Pubmed
- ↑ Google Scholar by Citation Google Scholar by Citation
- ↑ Skolkovo Commentary: Skolkovo scientist says AI and blockchain could accelerate biomedical research
- ↑ Bitcoin Tech Can Let You Decide Who Buys Your Data, Says Medical Startup
- ↑ This Biotech Company Wants You to Give it Selfies and Blood Tests in Exchange for Cryptocurrency
- ↑ []
- ↑ Alex Zhavoronkov presentation at the Exponential Medicine
- ↑ Singularity University Hub: AI to Scour a Universe of Molecules for Wonder Drugs
- ↑ Aging Editorial Board
- ↑ Frontiers in Genetics of Aging Editorial Board
- ↑ New Scientist report from the International Symposium on Geroprotectors in Basel
- ↑ 4th Annual Aging Research & Drug Discovery Forum in Basel, Switzerland
- ↑ Bloomberg Business week, Critic 07.22.2013 pp. 74
- ↑ CBS Radio with Dan Raviv in Washington, DC
- ↑ Book Tour Radio
